United States FOR PHYSICIANS ABOUT US NEWSROOM CONTACT US Who We Are Leadership Team Board of Directors Investors Careers Careers At Nevro, we are committed to developing ground breaking advances in spinal cord stimulation, which may make a meaningful difference in the lives of patients suffering with chronic pain. Nevro is a well-funded, high growth company with strong venture-capital and strategic partner support. We have assembled a passionate and dynamic team and we are interested in highly motivated and talented individuals. Headquartered in Menlo Park, California, Nevro is proud to offer our employees an excellent compensation and benefits package. Nevro is an equal opportunity employer. If you wish to be part of Nevro’s growing team, please email us at careers@nevro.com. To view a list of currently open positions, please click here. HIGH-FREQUENCY SCS Nevro is developing a new high-frequency stimulation technology for chronic pain. Learn More » CONTACT US Questions? Please contact us for more information. Home | For Physicians | About Us | Newsroom | Contact Us © 2014 Nevro Corp. All rights reserved. Legal Notice | Patents | Privacy The Senza® SCS system is an investigational device in the United States. It is limited by U.S. law to investigational use only. Senza, HF10, Nevro, and the Nevro logo are trademarks of Nevro Corp.

United States FOR PHYSICIANS ABOUT US NEWSROOM CONTACT US Who We Are Leadership Team Board of Directors Investors Careers Board Of Directors The Board of Directors at Nevro Corp. include veteran industry leaders with proven track records of success in bringing new therapies to market. We are fortunate to have the guidance of this strong group to help direct the growth of our company. Michael DeMane, Nevro Corp. – CEO Peter Bisgaard, Novo Ventures – Partner Michael Chuisano, Johnson & Johnson Development Corporation – VP, Venture Investments and Chief Operating Officer Frank Fischer, NeuroPace Inc. – CEO Wilfred Jaeger, Three Arch Partners – Partner John Nehra, New Enterprise Associates – Special Partner Nathan Pliam, Bay City Capital – Venture Partner HIGH-FREQUENCY SCS Nevro is developing a new high-frequency stimulation technology for chronic pain. Learn More » CONTACT US Questions? Please contact us for more information. Home | For Physicians | About Us | Newsroom | Contact Us © 2014 Nevro Corp. All rights reserved. Legal Notice | Patents | Privacy The Senza® SCS system is an investigational device in the United States. It is limited by U.S. law to investigational use only. Senza, HF10, Nevro, and the Nevro logo are trademarks of Nevro Corp.